Global Dabigatran Market Growth (Status and Outlook) 2025-2031

December 2025 | 91 pages | ID: G640522FCF8EN
LP Information

Abstracts

According to this study, the global Dabigatran market size will reach US$ million by 2031.

Dabigatran is an innovative anticoagulant, a new generation of thin blood drugs, known as the best drug for prevention of stroke in the past 60 years.

United States market for Dabigatran is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Dabigatran is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Dabigatran is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Dabigatran players cover Pfizer, Bayer Healthcare, GlaxoSmithKline, Boehringer Ingelheim, Aspen Holdings, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Dabigatran Industry Forecast” looks at past sales and reviews total world Dabigatran sales in 2024, providing a comprehensive analysis by region and market sector of projected Dabigatran sales for 2025 through 2031. With Dabigatran sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dabigatran industry.

This Insight Report provides a comprehensive analysis of the global Dabigatran landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Dabigatran portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dabigatran market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dabigatran and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dabigatran.

This report presents a comprehensive overview, market shares, and growth opportunities of Dabigatran market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Tablets
• Capsule
• Others

Segmentation by Application:

• Deep Vein Thrombosis
• Pulmonary Embolism
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Bayer Healthcare
• GlaxoSmithKline
• Boehringer Ingelheim
• Aspen Holdings
• Bristol-Myers Squibb Company
• Teva Pharmaceutical Industries

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Dabigatran Market Size (2020-2031)
  2.1.2 Dabigatran Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Dabigatran by Country/Region (2020, 2024 & 2031)
2.2 Dabigatran Segment by Type
  2.2.1 Tablets
  2.2.2 Capsule
  2.2.3 Others
2.3 Dabigatran Market Size by Type
  2.3.1 Dabigatran Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Dabigatran Market Size Market Share by Type (2020-2025)
2.4 Dabigatran Segment by Application
  2.4.1 Deep Vein Thrombosis
  2.4.2 Pulmonary Embolism
  2.4.3 Others
2.5 Dabigatran Market Size by Application
  2.5.1 Dabigatran Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Dabigatran Market Size Market Share by Application (2020-2025)

3 DABIGATRAN MARKET SIZE BY PLAYER

3.1 Dabigatran Market Size Market Share by Player
  3.1.1 Global Dabigatran Revenue by Player (2020-2025)
  3.1.2 Global Dabigatran Revenue Market Share by Player (2020-2025)
3.2 Global Dabigatran Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 DABIGATRAN BY REGION

4.1 Dabigatran Market Size by Region (2020-2025)
4.2 Global Dabigatran Annual Revenue by Country/Region (2020-2025)
4.3 Americas Dabigatran Market Size Growth (2020-2025)
4.4 APAC Dabigatran Market Size Growth (2020-2025)
4.5 Europe Dabigatran Market Size Growth (2020-2025)
4.6 Middle East & Africa Dabigatran Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Dabigatran Market Size by Country (2020-2025)
5.2 Americas Dabigatran Market Size by Type (2020-2025)
5.3 Americas Dabigatran Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Dabigatran Market Size by Region (2020-2025)
6.2 APAC Dabigatran Market Size by Type (2020-2025)
6.3 APAC Dabigatran Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Dabigatran Market Size by Country (2020-2025)
7.2 Europe Dabigatran Market Size by Type (2020-2025)
7.3 Europe Dabigatran Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Dabigatran by Region (2020-2025)
8.2 Middle East & Africa Dabigatran Market Size by Type (2020-2025)
8.3 Middle East & Africa Dabigatran Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL DABIGATRAN MARKET FORECAST

10.1 Global Dabigatran Forecast by Region (2026-2031)
  10.1.1 Global Dabigatran Forecast by Region (2026-2031)
  10.1.2 Americas Dabigatran Forecast
  10.1.3 APAC Dabigatran Forecast
  10.1.4 Europe Dabigatran Forecast
  10.1.5 Middle East & Africa Dabigatran Forecast
10.2 Americas Dabigatran Forecast by Country (2026-2031)
  10.2.1 United States Market Dabigatran Forecast
  10.2.2 Canada Market Dabigatran Forecast
  10.2.3 Mexico Market Dabigatran Forecast
  10.2.4 Brazil Market Dabigatran Forecast
10.3 APAC Dabigatran Forecast by Region (2026-2031)
  10.3.1 China Dabigatran Market Forecast
  10.3.2 Japan Market Dabigatran Forecast
  10.3.3 Korea Market Dabigatran Forecast
  10.3.4 Southeast Asia Market Dabigatran Forecast
  10.3.5 India Market Dabigatran Forecast
  10.3.6 Australia Market Dabigatran Forecast
10.4 Europe Dabigatran Forecast by Country (2026-2031)
  10.4.1 Germany Market Dabigatran Forecast
  10.4.2 France Market Dabigatran Forecast
  10.4.3 UK Market Dabigatran Forecast
  10.4.4 Italy Market Dabigatran Forecast
  10.4.5 Russia Market Dabigatran Forecast
10.5 Middle East & Africa Dabigatran Forecast by Region (2026-2031)
  10.5.1 Egypt Market Dabigatran Forecast
  10.5.2 South Africa Market Dabigatran Forecast
  10.5.3 Israel Market Dabigatran Forecast
  10.5.4 Turkey Market Dabigatran Forecast
10.6 Global Dabigatran Forecast by Type (2026-2031)
10.7 Global Dabigatran Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Dabigatran Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Dabigatran Product Offered
  11.1.3 Pfizer Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Bayer Healthcare
  11.2.1 Bayer Healthcare Company Information
  11.2.2 Bayer Healthcare Dabigatran Product Offered
  11.2.3 Bayer Healthcare Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer Healthcare Main Business Overview
  11.2.5 Bayer Healthcare Latest Developments
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Information
  11.3.2 GlaxoSmithKline Dabigatran Product Offered
  11.3.3 GlaxoSmithKline Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GlaxoSmithKline Main Business Overview
  11.3.5 GlaxoSmithKline Latest Developments
11.4 Boehringer Ingelheim
  11.4.1 Boehringer Ingelheim Company Information
  11.4.2 Boehringer Ingelheim Dabigatran Product Offered
  11.4.3 Boehringer Ingelheim Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Boehringer Ingelheim Main Business Overview
  11.4.5 Boehringer Ingelheim Latest Developments
11.5 Aspen Holdings
  11.5.1 Aspen Holdings Company Information
  11.5.2 Aspen Holdings Dabigatran Product Offered
  11.5.3 Aspen Holdings Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Aspen Holdings Main Business Overview
  11.5.5 Aspen Holdings Latest Developments
11.6 Bristol-Myers Squibb Company
  11.6.1 Bristol-Myers Squibb Company Company Information
  11.6.2 Bristol-Myers Squibb Company Dabigatran Product Offered
  11.6.3 Bristol-Myers Squibb Company Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Bristol-Myers Squibb Company Main Business Overview
  11.6.5 Bristol-Myers Squibb Company Latest Developments
11.7 Teva Pharmaceutical Industries
  11.7.1 Teva Pharmaceutical Industries Company Information
  11.7.2 Teva Pharmaceutical Industries Dabigatran Product Offered
  11.7.3 Teva Pharmaceutical Industries Dabigatran Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Teva Pharmaceutical Industries Main Business Overview
  11.7.5 Teva Pharmaceutical Industries Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Dabigatran Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Dabigatran Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsule
Table 5. Major Players of Others
Table 6. Dabigatran Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Dabigatran Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Dabigatran Market Size Market Share by Type (2020-2025)
Table 9. Dabigatran Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Dabigatran Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Dabigatran Market Size Market Share by Application (2020-2025)
Table 12. Global Dabigatran Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Dabigatran Revenue Market Share by Player (2020-2025)
Table 14. Dabigatran Key Players Head office and Products Offered
Table 15. Dabigatran Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Dabigatran Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Dabigatran Market Size Market Share by Region (2020-2025)
Table 20. Global Dabigatran Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Dabigatran Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Dabigatran Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Dabigatran Market Size Market Share by Country (2020-2025)
Table 24. Americas Dabigatran Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Dabigatran Market Size Market Share by Type (2020-2025)
Table 26. Americas Dabigatran Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Dabigatran Market Size Market Share by Application (2020-2025)
Table 28. APAC Dabigatran Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Dabigatran Market Size Market Share by Region (2020-2025)
Table 30. APAC Dabigatran Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Dabigatran Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Dabigatran Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Dabigatran Market Size Market Share by Country (2020-2025)
Table 34. Europe Dabigatran Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Dabigatran Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Dabigatran Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Dabigatran Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Dabigatran Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Dabigatran
Table 40. Key Market Challenges & Risks of Dabigatran
Table 41. Key Industry Trends of Dabigatran
Table 42. Global Dabigatran Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Dabigatran Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Dabigatran Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Dabigatran Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Dabigatran Area Served and Its Competitors
Table 47. Pfizer Dabigatran Product Offered
Table 48. Pfizer Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Bayer Healthcare Details, Company Type, Dabigatran Area Served and Its Competitors
Table 52. Bayer Healthcare Dabigatran Product Offered
Table 53. Bayer Healthcare Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Bayer Healthcare Main Business
Table 55. Bayer Healthcare Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Dabigatran Area Served and Its Competitors
Table 57. GlaxoSmithKline Dabigatran Product Offered
Table 58. GlaxoSmithKline Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Boehringer Ingelheim Details, Company Type, Dabigatran Area Served and Its Competitors
Table 62. Boehringer Ingelheim Dabigatran Product Offered
Table 63. Boehringer Ingelheim Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Boehringer Ingelheim Main Business
Table 65. Boehringer Ingelheim Latest Developments
Table 66. Aspen Holdings Details, Company Type, Dabigatran Area Served and Its Competitors
Table 67. Aspen Holdings Dabigatran Product Offered
Table 68. Aspen Holdings Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Aspen Holdings Main Business
Table 70. Aspen Holdings Latest Developments
Table 71. Bristol-Myers Squibb Company Details, Company Type, Dabigatran Area Served and Its Competitors
Table 72. Bristol-Myers Squibb Company Dabigatran Product Offered
Table 73. Bristol-Myers Squibb Company Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Bristol-Myers Squibb Company Main Business
Table 75. Bristol-Myers Squibb Company Latest Developments
Table 76. Teva Pharmaceutical Industries Details, Company Type, Dabigatran Area Served and Its Competitors
Table 77. Teva Pharmaceutical Industries Dabigatran Product Offered
Table 78. Teva Pharmaceutical Industries Dabigatran Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Teva Pharmaceutical Industries Main Business
Table 80. Teva Pharmaceutical Industries Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Dabigatran Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dabigatran Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Dabigatran Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Dabigatran Sales Market Share by Country/Region (2024)
Figure 8. Dabigatran Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Dabigatran Market Size Market Share by Type in 2024
Figure 10. Dabigatran in Deep Vein Thrombosis
Figure 11. Global Dabigatran Market: Deep Vein Thrombosis (2020-2025) & ($ millions)
Figure 12. Dabigatran in Pulmonary Embolism
Figure 13. Global Dabigatran Market: Pulmonary Embolism (2020-2025) & ($ millions)
Figure 14. Dabigatran in Others
Figure 15. Global Dabigatran Market: Others (2020-2025) & ($ millions)
Figure 16. Global Dabigatran Market Size Market Share by Application in 2024
Figure 17. Global Dabigatran Revenue Market Share by Player in 2024
Figure 18. Global Dabigatran Market Size Market Share by Region (2020-2025)
Figure 19. Americas Dabigatran Market Size 2020-2025 ($ millions)
Figure 20. APAC Dabigatran Market Size 2020-2025 ($ millions)
Figure 21. Europe Dabigatran Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Dabigatran Market Size 2020-2025 ($ millions)
Figure 23. Americas Dabigatran Value Market Share by Country in 2024
Figure 24. United States Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Dabigatran Market Size Market Share by Region in 2024
Figure 29. APAC Dabigatran Market Size Market Share by Type (2020-2025)
Figure 30. APAC Dabigatran Market Size Market Share by Application (2020-2025)
Figure 31. China Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 35. India Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Dabigatran Market Size Market Share by Country in 2024
Figure 38. Europe Dabigatran Market Size Market Share by Type (2020-2025)
Figure 39. Europe Dabigatran Market Size Market Share by Application (2020-2025)
Figure 40. Germany Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 41. France Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Dabigatran Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Dabigatran Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Dabigatran Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Dabigatran Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Dabigatran Market Size 2026-2031 ($ millions)
Figure 54. APAC Dabigatran Market Size 2026-2031 ($ millions)
Figure 55. Europe Dabigatran Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Dabigatran Market Size 2026-2031 ($ millions)
Figure 57. United States Dabigatran Market Size 2026-2031 ($ millions)
Figure 58. Canada Dabigatran Market Size 2026-2031 ($ millions)
Figure 59. Mexico Dabigatran Market Size 2026-2031 ($ millions)
Figure 60. Brazil Dabigatran Market Size 2026-2031 ($ millions)
Figure 61. China Dabigatran Market Size 2026-2031 ($ millions)
Figure 62. Japan Dabigatran Market Size 2026-2031 ($ millions)
Figure 63. Korea Dabigatran Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Dabigatran Market Size 2026-2031 ($ millions)
Figure 65. India Dabigatran Market Size 2026-2031 ($ millions)
Figure 66. Australia Dabigatran Market Size 2026-2031 ($ millions)
Figure 67. Germany Dabigatran Market Size 2026-2031 ($ millions)
Figure 68. France Dabigatran Market Size 2026-2031 ($ millions)
Figure 69. UK Dabigatran Market Size 2026-2031 ($ millions)
Figure 70. Italy Dabigatran Market Size 2026-2031 ($ millions)
Figure 71. Russia Dabigatran Market Size 2026-2031 ($ millions)
Figure 72. Egypt Dabigatran Market Size 2026-2031 ($ millions)
Figure 73. South Africa Dabigatran Market Size 2026-2031 ($ millions)
Figure 74. Israel Dabigatran Market Size 2026-2031 ($ millions)
Figure 75. Turkey Dabigatran Market Size 2026-2031 ($ millions)
Figure 76. Global Dabigatran Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Dabigatran Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Dabigatran Market Size 2026-2031 ($ millions)